StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
MNOV

MediciNova, Inc.

MNOV Nasdaq Pharmaceutical Preparations EDGAR ↗
$1.33
-0.01 -0.75%

Key statistics

from XBRL data in SEC filings
Market cap
$65.5M
Revenue (TTM)
$410K
Net income (TTM)
$12.3M
EPS (TTM)
$-0.23
P/E ratio
Dividend yield
Free cash flow
-$9.81M
Cash
$27.3M
Total assets
$42.7M
Gross margin
52-week range
$1.17 – $1.96

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Shareholder vote results Jun 24, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 10-K Fiscal year ended 2025-12-31 Mar 10, 2026 8-K Results of operations (earnings release) Feb 20, 2026 8-K Entered a material agreement Dec 30, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Entered a material agreement Aug 1, 2025 8-K Shareholder vote results Jun 18, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Regulation FD disclosure Mar 11, 2025 10-K Fiscal year ended 2024-12-31 Feb 19, 2025 10-Q Quarter ended 2024-09-30 Nov 13, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Shareholder vote results Jun 12, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Director or officer change Apr 1, 2024 10-K Fiscal year ended 2023-12-31 Feb 15, 2024 10-Q Quarter ended 2023-09-30 Nov 9, 2023 10-Q Quarter ended 2023-06-30 Aug 9, 2023 8-K Director or officer change Aug 7, 2023 8-K Delisting notice or listing-rule failure Jun 22, 2023 8-K Shareholder vote results Jun 14, 2023 10-Q Quarter ended 2023-03-31 May 11, 2023 8-K Director or officer change Apr 26, 2023 10-K/A Fiscal year ended 2022-12-31 Mar 28, 2023 10-K Fiscal year ended 2022-12-31 Feb 16, 2023 10-Q Quarter ended 2022-09-30 Nov 10, 2022 10-Q Quarter ended 2022-06-30 Aug 11, 2022 8-K Director or officer change Jun 21, 2022 8-K Shareholder vote results Jun 15, 2022 10-Q Quarter ended 2022-03-31 May 12, 2022 8-K Other events Apr 5, 2022 10-K Fiscal year ended 2021-12-31 Feb 16, 2022 10-Q Quarter ended 2021-09-30 Nov 12, 2021 10-Q Quarter ended 2021-06-30 Aug 12, 2021 8-K Director or officer change Aug 2, 2021 8-K Entered a material agreement Jul 23, 2021 8-K Shareholder vote results Jun 17, 2021 8-K Other events May 18, 2021